PCH
NPCE icon

Polar Capital Holdings’s Neuropace NPCE Stock Holding History

Polar Capital Holdings’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.4M Buy
3,298,104
+419,581
+15% +$6.29M 0.15% 110
2025
Q4 		$44.4M Sell
2,878,523
-219,345
-7% -$2.93M 0.17% 105
2025
Q3 		$31.9M Buy
+3,097,868
New +$29.2M 0.15% 112
2025
Q2 		– Sell
-2,972,003
Closed -$37.2M – 297
2025
Q1 		$36.5M Buy
+2,972,003
New +$37.2M 0.22% 113

Other funds holding NPCE

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Polar Capital Holdings's NPCE Position: Q1 2026 in Review

Polar Capital Holdings increased its Neuropace (NPCE) stake by 15% in Q1 2026, buying an estimated $6.29M and bringing the position to 3,298,104 shares worth $43.4M. The position accounts for 0.15% of the portfolio, ranked #110.

Polar Capital Holdings first reported a position in NPCE in Q1 2025 and has held it in 4 quarters since. The position peaked at $44.4M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Polar Capital Holdings held 3,298,104 shares of Neuropace worth $43.4M as of Q1 2026.
  • Polar Capital Holdings bought 419,581 Neuropace shares in Q1 2026, an estimated $6.29M.
  • Neuropace made up 0.15% of Polar Capital Holdings's portfolio in Q1 2026, its #110 holding.
  • Polar Capital Holdings first reported a position in Neuropace in Q1 2025 and has held it in 4 quarters since.
  • Polar Capital Holdings's Neuropace position peaked at $44.4M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Polar Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.